Načítá se...
ROCKET AF adds more concerns about Digoxin safety in patients with atrial fibrillation
In a recent article in the Journal, we have reviewed the adverse cardiovascular outcomes observed with digoxin use in the PALLAS study.(1) The PALLAS study was designed to determine if dronedarone would reduce major vascular events in patients with permanent atrial fibrillation (AF).(2) However the...
Uloženo v:
| Vydáno v: | Glob Cardiol Sci Pract |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Bloomsbury Qatar Foundation Journals
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4633576/ https://ncbi.nlm.nih.gov/pubmed/26779514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5339/gcsp.2015.35 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|